Colorectal cancer (colorectal cancer, CRC) is the third most common malignant tumor globally and the second leading cause of cancer-related deaths. Colonoscopy is considered the preferred method for screening colorectal cancer; early detection and removal of colorectal neoplasms can significantly reduce the incidence and mortality of colorectal cancer. To improve the diagnostic accuracy of endoscopy in colorectal lesions, many endoscopic techniques have been applied clinically, such as image-enhanced endoscopy, including narrow band imaging (narrow-band imaging, NBI), magnifying endoscopy, chromoendoscopy, confocal laser endoscopy, and endocytoscopy (EC). However, with the increasing number of endoscopic resections, the costs associated with the pathological diagnosis of resected specimens have risen year by year. In clinical practice, some non-neoplastic colorectal lesions may not require resection, so it is important to differentiate the nature of lesions during colonoscopy. Endocytoscopy is an ultra-high magnification endoscope that, when combined with chemical staining and narrowband imaging techniques, allows endoscopists to observe the nuclear morphology of colorectal lesions, the shape of glands, and the morphology of microvessels with the naked eye, thus avoiding pathological examination and achieving the goal of real-time biopsy in vivo. However, the accuracy of endocytoscopy images requires extensive experience accumulation to improve judgment, and there is a certain degree of subjectivity and error in the process of endoscopists making judgments. Therefore, to address this issue, clinical applications have proposed using artificial intelligence (AI) for computer-aided diagnosis. Currently, Japan has developed an endoscopic cytology auxiliary diagnostic system-EndoBRAIN, based on the Japanese population, which uses support vector machines to build model. The investigator's center has developed a deep learning-based endoscopic cytology AI auxiliary diagnostic system for Chinese populations to assist in determining the nature of colorectal lesions. There is currently a lack of comparative studies on the diagnostic performance of these two systems, so the investigator aim to conduct a clinical study to compare and analyze the differences between the two AI auxiliary diagnostic systems.
Study Type
OBSERVATIONAL
Enrollment
500
Different AI assisted diagnostic systems are used to diagnose lesions.
First Hospital of Jilin University
Changchun, Jilin, China
RECRUITINGthe sensitivity of two AI assisted diagnostic systems for diagnosing colorectal neoplasms
of the intracellular AI platform for diagnosing colorectal neoplastic lesions was not inferior to that of EndoBRAIN.
Time frame: 2025-12-31
the accuracy of two AI assisted diagnostic systems for diagnosing colorectal neoplasms
Time frame: 2025-12-31
specificity of two AI assisted diagnostic systems for diagnosing colorectal neoplasms
Time frame: 2025-12-31
positive predictive value of two AI assisted diagnostic systems for diagnosing colorectal neoplasms
Time frame: 2025-12-31
negative predictive value of two AI assisted diagnostic systems for diagnosing colorectal neoplasms
Time frame: 2025-12-31
the accuracy of two AI assisted diagnostic systems for diagnosing colorectal invasive cancer
Time frame: 2025-12-31
The accuracy of two AI assisted diagnostic systems in diagnosing lesions of the rectoileal colon ≤5 mm
Time frame: 2025-12-31
the high confidence diagnosis rate of two AI assisted diagnostic systems for diagnosing colorectal lesions
Time frame: 2025-12-31
the diagnostic time of two artificial intelligence assisted diagnosis systems
Time frame: 2025-12-31
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.